Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)
Hong Kong · Delayed Price · Currency is HKD 0.1070
-0.0020 (-1.83%)
Jul 31, 2026, 2:57 PM HKT
HKG:8329 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 972.01 | 972.01 | 1,042 | 1,065 | 986.69 | 838.81 |
Revenue Growth | -2.13% | -6.69% | -2.17% | 7.92% | 17.63% | -18.67% |
Gross Profit Gross Profit Growth | 287.22 | 287.22 | 328.04 | 439.24 | 443.68 | 368.13 |
Operating Income Operating Income Growth | 20.57 | 20.57 | 34.78 | 48.18 | 85.42 | 35.75 |
Net Income Net Income Growth | -40.74 | -40.74 | 25.01 | 24.13 | 54.35 | 35.96 |
Earnings Per Share EPS Growth | -0.02 | -0.02 | 0.01 | 0.01 | 0.03 | 0.02 |
EPS Growth | - | - | 3.68% | -55.61% | 51.14% | -1.73% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Manufacturing and Selling of Medicines and Medical Devices Manufacturing and Selling of Medicines and Medical Devices Growth | 551.5 | 551.5 | 576.48 | 611.48 | 724.77 | 547.8 |
Sales and Distribution of Medicines and Healthcare Products and Medical Devices Sales and Distribution of Medicines and Healthcare Products and Medical Devices Growth | 490 | 490 | 523.05 | 554.63 | 326.96 | 337.32 |
Elimination of Inter-Segment Elimination of Inter-Segment Growth | -69.49 | -69.49 | -57.83 | -101.25 | -65.05 | -46.31 |
Total Total Growth | 972.01 | 972.01 | 1,042 | 1,065 | 986.69 | 838.81 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 209.36 | 209.36 | 283.42 | 382.21 | 350.1 | 311.14 |
Total Debt Total Debt Growth | 72.99 | 72.99 | 105.43 | 89.69 | 92.69 | 105.69 |
Net Cash (Debt) Net Cash Growth | 136.37 | 136.37 | 177.99 | 292.52 | 257.41 | 205.45 |
Net Cash Growth | 264.25% | -23.39% | -39.15% | 13.64% | 25.29% | -49.38% |
Net Cash Per Share Net Cash Per Share Growth | 0.08 | 0.08 | 0.11 | 0.17 | 0.15 | 0.12 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 139.59 | 139.59 | 24.41 | 53.69 | 61.22 | -69.92 |
Capital Expenditures CapEx Growth | -11.3 | -11.3 | -19.13 | -15.21 | -19.69 | -11.72 |
Free Cash Flow Free Cash Flow Growth | 128.29 | 128.29 | 5.28 | 38.47 | 41.53 | -81.64 |
Free Cash Flow Growth | 307.91% | 2328.39% | -86.27% | -7.35% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 29.55% | 29.55% | 31.49% | 41.25% | 44.97% | 43.89% |
Operating Margin | 2.12% | 2.12% | 3.34% | 4.52% | 8.66% | 4.26% |
Pretax Margin | -5.00% | -5.00% | 2.85% | 2.88% | 8.34% | 4.66% |
Profit Margin | -4.19% | -4.19% | 2.40% | 2.27% | 5.51% | 4.29% |
FCF Margin | 13.20% | 13.20% | 0.51% | 3.61% | 4.21% | -9.73% |
| Fiscal Year | FY 2024 |
|---|---|
| Period Ending | Dec '24 Dec 31, 2024 |
Dividend Per Share Dividend Per Share Growth | 0.005 |
Dividend Per Share Growth | - |
Dividend Yield | 5.91% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 10.28 | 10.35 | 4.70 | 7.03 |
P/FCF Ratio | 1.26 | 1.87 | 48.65 | 6.49 | 6.15 | - |
PS Ratio | 0.17 | 0.25 | 0.25 | 0.24 | 0.26 | 0.30 |